Live from the NIH registry
Studies recruiting near Metairie right now
Top 25 of 522 recruiting studies, sorted by proximity — each links to its official registry page
Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
Hiatal Hernia
N/A
Interventional 200 participants sought
Louisiana State University School of Medicine — New Orleans, Louisiana (6.8 mi)
· Sponsor: Weill Medical College of Cornell University
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (6.8 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Tulane University — New Orleans, Louisiana (6.8 mi)
· Sponsor: Jaeb Center for Health Research
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
East Jefferson Hospital — Metairie, Louisiana (1.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — New Orleans, Louisiana (6.8 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Ochsner Clinic Foundation ( Site 0021) — New Orleans, Louisiana (6.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: Pfizer
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
East Jefferson General Hospital — Metairie, Louisiana (1.8 mi)
· Sponsor: Pfizer
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: Children's Oncology Group
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
East Jefferson General Hospital — Metairie, Louisiana (1.8 mi)
· Sponsor: NRG Oncology
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation
Phase 1
Interventional 420 participants sought
Ochsner MD Anderson Cancer Center — Jefferson, Louisiana (2.6 mi)
· Sponsor: Kura Oncology, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
GI Alliance - Gastro Group and Endocenter - Mandeville — Mandeville, Louisiana (25.8 mi)
· Sponsor: Eli Lilly and Company
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
BRCR Global Louisiana — Gretna, Louisiana (9.4 mi)
· Sponsor: Alveus Therapeutics, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Tulane University School of Medicine — New Orleans, Louisiana (6.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
LSU Health Sciences — New Orleans, Louisiana (6.8 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Tandem Clinical Research — Metairie, Louisiana (1.8 mi)
· Sponsor: Regeneron Pharmaceuticals
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 2
Interventional 200 participants sought
UMC New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Refractory Metastatic Colorectal Cancer
Phase 2
Interventional 90 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (6.8 mi)
· Sponsor: Delcath Systems Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: NRG Oncology
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
NOLA Care Clinical Research — Metairie, Louisiana (1.8 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (6.8 mi)
· Sponsor: NRG Oncology
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 180 participants sought
Southeast Louisiana Veterans Health Care System, New Orleans, LA — New Orleans, Louisiana (6.8 mi)
· Sponsor: VA Office of Research and Development
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 105 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (6.8 mi)
· Sponsor: ImmunoGenesis